These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 15205471)
1. Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases. Onan D; Pipolo L; Yang E; Hannan RD; Thomas WG Mol Endocrinol; 2004 Sep; 18(9):2344-54. PubMed ID: 15205471 [TBL] [Abstract][Full Text] [Related]
2. Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts. Chen YL; Liu JC; Loh SH; Chen CH; Hong CY; Chen JJ; Cheng TH Eur J Pharmacol; 2008 Sep; 593(1-3):24-9. PubMed ID: 18671962 [TBL] [Abstract][Full Text] [Related]
3. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705 [TBL] [Abstract][Full Text] [Related]
4. A novel role of G protein-coupled receptor kinase 5 in urotensin II-stimulated cellular hypertrophy in H9c2 Park CH; Lee JH; Lee MY; Lee JH; Lee BH; Oh KS Mol Cell Biochem; 2016 Nov; 422(1-2):151-160. PubMed ID: 27613164 [TBL] [Abstract][Full Text] [Related]
5. Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor. Liu JC; Chen CH; Chen JJ; Cheng TH Mol Pharmacol; 2009 Dec; 76(6):1186-95. PubMed ID: 19755521 [TBL] [Abstract][Full Text] [Related]
6. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Johns DG; Ao Z; Naselsky D; Herold CL; Maniscalco K; Sarov-Blat L; Steplewski K; Aiyar N; Douglas SA Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):238-50. PubMed ID: 15549273 [TBL] [Abstract][Full Text] [Related]
7. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917 [TBL] [Abstract][Full Text] [Related]
8. Urotensin II prevents cardiomyocyte apoptosis induced by doxorubicin via Akt and ERK. Chen YL; Loh SH; Chen JJ; Tsai CS Eur J Pharmacol; 2012 Apr; 680(1-3):88-94. PubMed ID: 22329895 [TBL] [Abstract][Full Text] [Related]
9. Cafestol Activates Nuclear Factor Erythroid-2 Related Factor 2 and Inhibits Urotensin II-Induced Cardiomyocyte Hypertrophy. Hao WR; Sung LC; Chen CC; Hong HJ; Liu JC; Chen JJ Am J Chin Med; 2019; 47(2):337-350. PubMed ID: 30871360 [TBL] [Abstract][Full Text] [Related]
10. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway. Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483 [TBL] [Abstract][Full Text] [Related]
11. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes. Nakaoka Y; Nishida K; Fujio Y; Izumi M; Terai K; Oshima Y; Sugiyama S; Matsuda S; Koyasu S; Yamauchi-Takihara K; Hirano T; Kawase I; Hirota H Circ Res; 2003 Aug; 93(3):221-9. PubMed ID: 12855672 [TBL] [Abstract][Full Text] [Related]
12. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. D'Amore A; Black MJ; Thomas WG Hypertension; 2005 Dec; 46(6):1347-54. PubMed ID: 16286564 [TBL] [Abstract][Full Text] [Related]
13. [Autocrine/paracrine role of urotensin II as a growth factor]. Yoshimoto T; Hirata Y Nihon Rinsho; 2004 Sep; 62 Suppl 9():711-4. PubMed ID: 15506479 [No Abstract] [Full Text] [Related]
14. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes. Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor-dependent and -independent pathways in hydrogen peroxide-induced mitogen-activated protein kinase activation in cardiomyocytes and heart fibroblasts. Purdom S; Chen QM J Pharmacol Exp Ther; 2005 Mar; 312(3):1179-86. PubMed ID: 15574683 [TBL] [Abstract][Full Text] [Related]
16. Selective involvement of p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK activation. Kodama H; Fukuda K; Takahashi E; Tahara S; Tomita Y; Ieda M; Kimura K; Owada KM; Vuori K; Ogawa S Hypertension; 2003 Jun; 41(6):1372-9. PubMed ID: 12719447 [TBL] [Abstract][Full Text] [Related]
17. Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats. Zou Y; Nagai R; Yamazaki T FEBS Lett; 2001 Nov; 508(1):57-60. PubMed ID: 11707268 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II and the JNK pathway mediate urotensin II expression in response to hypoxia in rat cardiomyocytes. Chiu CZ; Wang BW; Shyu KG J Endocrinol; 2014 Mar; 220(3):233-46. PubMed ID: 24481965 [TBL] [Abstract][Full Text] [Related]
19. EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy. Esposito G; Perrino C; Cannavo A; Schiattarella GG; Borgia F; Sannino A; Pironti G; Gargiulo G; Di Serafino L; Franzone A; Scudiero L; Grieco P; Indolfi C; Chiariello M Basic Res Cardiol; 2011 Jun; 106(4):577-89. PubMed ID: 21369867 [TBL] [Abstract][Full Text] [Related]
20. Peroxynitrite modulates the activation of p38 and extracellular regulated kinases in PC12 cells. Jope RS; Zhang L; Song L Arch Biochem Biophys; 2000 Apr; 376(2):365-70. PubMed ID: 10775424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]